The Irony of Metastatic Breast Cancer – Mary Huckle

Many of our followers on social media will remember Mary Huckle and her tireless campaigning for #metastaticbreastcancer awareness. This blog post is the last content she wrote for us, a

How smarter therapies can help metastatic breast cancer patients – and why we need more!

Why we need MBC research more than ever

At METUPUK, we campaign for new and better therapies for patients with secondary breast cancer. One of our recent campaigns, #TrodelvyNow helped to make a new type of drug, Trodelvy (sacituzumab govitecan) available for SBC patients in the UK. Scientist and METUPUK volunteer, Helen, explains how Trodelvy works and why it’s important that more drugs like this get to patients urgently.

Statistics for Metastatic Breast Cancer

Statistics for Metastatic Breast Cancer

We started our campaign in Metastatic May with some information about treatment lines and it really caused a bit of a stir, especially on Instagram.

Why? Because people don’t want to think that this disease is going to kill us. We have to remain positive. We have to see the chink of light and I agree we all have to have hope. That was my introduction. We need hope.

Drugs, Drugs, Drugs

Drugs, drugs, drugs, like patching up a sinking boat

I think sometimes when those outside the cancer world imagine what treatment is like they think we go in, have some chemo, take some photos dancing around our IV pole and then go home and rest for a few days…. And don’t get me wrong I’m one of those people who have taken a cheeky chemo selfie and donned numerous items of leopard print to get me through those loooooooong days in the chemo ward, it’s like armour for what is essentially ritual poisoning! 

A Real Life Accounts of Accessing Clinical Trials

Clinical trials

In 2018 I was diagnosed with secondary breast cancer in my liver, I was 44.

I knew the survival statistics were grim, so decided from the outset, in order to outlive the 2 to 3-year median I’d have to embrace experimental drugs and treatments.

I made this clear during my first oncology appointment, telling my doctor I was keen to sign up for clinical trials right from the start.